Zealand touts safe­ty of new ‘dou­ble-G’ drug de­spite mod­est weight loss in small tri­al

Zealand Phar­ma ap­pears to have tak­en a small step for­ward with a can­di­date that tar­gets both GLP-1 and GLP-2, an ap­proach that aims to ease …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.